Clinical Trial

Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-21.
Status change: Not Yet Recruiting → Recruiting 2025-12-13
Trial Details
NCT Number NCT07091526
Lead Sponsor Hepatopancreatobiliary Surgery Institute of Gansu Province
Conditions Serum Uric Acid
Enrollment 168 participants
Start Date 2025-07-29
Primary Completion 2026-12-29 (estimated)
Study Completion 2026-12-29 (estimated)
Updated on ClinicalTrials.gov 2025-12-19